Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
29 January 2008Website:
http://www.lifemd.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 35 min agoDividend
Analysts recommendations
Institutional Ownership
LFMD Latest News
NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
LifeMD Inc. NASDAQ: LFMD is a leading telehealth provider operating an end-to-end virtual healthcare platform. LifeMD operates a direct-to-consumer (DTC) model focused on offering on-demand primary care services to consumers.
LifeMD Inc. NASDAQ: LFMD provides telehealth services to consumers in the United States. The medical sector company operates many telehealth brands, including men's telehealth brands RexMD and ShapiroMD, NavaMD female dermatology telehealth, Cleared Allergy Clinic, and LifeMD Primary Care.
LifeMD, Inc. (NASDAQ:LFMD ) Q4 2023 Earnings Conference Call March 11, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - CFO Conference Call Participants David Larsen - BTIG William Wood - B. Riley Alex Fuhrman - Craig-Hallum Ilya Zubkov - Freedom Broker Yi Chen - H.C.
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.02 per share a year ago.
LifeMD Inc. NASDAQ: LFMD is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing with no health insurance required.
LifeMD is recording strong growth figures on the back of WorkSimpli, its SaaS offering. The company currently sports an 87.62% gross profit margin and generated positive operating cash flow for its most recent quarter. Gross profit margins will see strength through 2024 as market sentiment toward growth stocks recovers to set the backdrop for continued outperformance.
LifeMD, Inc.'s share price is soaring, once again. The company's focus on GLP-1 medications integration and primary care services exemplifies its commitment to comprehensive patient care. Its consistent increase in its share count could potentially dilute its progress.
LifeMD reached positive operating cash flow for the first time during its fiscal 2023 second quarter. This boosted the telehealth company's cash and equivalents position and formed an inflection point for its investment pitch. WorkSimpli is experiencing material year-over-year growth and could exit LifeMD's fiscal 2024 with a $100 million revenue run rate.
Primarily, one reason stands above all the others regarding the incentive behind stocks with insider buying: those who are closest to a particular business would only be buying shares if they believed the stock would rise higher. Otherwise, if they felt convinced that the business could tumble, they would probably exit their holdings.
What type of business is LifeMD?
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
What sector is LifeMD in?
LifeMD is in the Healthcare sector
What industry is LifeMD in?
LifeMD is in the Health Information Services industry
What country is LifeMD from?
LifeMD is headquartered in United States
When did LifeMD go public?
LifeMD initial public offering (IPO) was on 29 January 2008
What is LifeMD website?
https://www.lifemd.com
Is LifeMD in the S&P 500?
No, LifeMD is not included in the S&P 500 index
Is LifeMD in the NASDAQ 100?
No, LifeMD is not included in the NASDAQ 100 index
Is LifeMD in the Dow Jones?
No, LifeMD is not included in the Dow Jones index
When does LifeMD report earnings?
The next expected earnings date for LifeMD is 09 August 2024